JP2025506201A5 - - Google Patents
Info
- Publication number
- JP2025506201A5 JP2025506201A5 JP2024547842A JP2024547842A JP2025506201A5 JP 2025506201 A5 JP2025506201 A5 JP 2025506201A5 JP 2024547842 A JP2024547842 A JP 2024547842A JP 2024547842 A JP2024547842 A JP 2024547842A JP 2025506201 A5 JP2025506201 A5 JP 2025506201A5
- Authority
- JP
- Japan
- Prior art keywords
- disorder
- disease
- disability
- disorders
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263310219P | 2022-02-15 | 2022-02-15 | |
| US63/310,219 | 2022-02-15 | ||
| PCT/US2023/012660 WO2023158584A1 (en) | 2022-02-15 | 2023-02-09 | New bicyclopentane derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506201A JP2025506201A (ja) | 2025-03-07 |
| JP2025506201A5 true JP2025506201A5 (https=) | 2026-02-24 |
Family
ID=85781948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547842A Pending JP2025506201A (ja) | 2022-02-15 | 2023-02-09 | 新規なビシクロペンタン誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250002452A1 (https=) |
| EP (1) | EP4479377A1 (https=) |
| JP (1) | JP2025506201A (https=) |
| CN (1) | CN118829626A (https=) |
| WO (1) | WO2023158584A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025252599A1 (en) * | 2024-06-04 | 2025-12-11 | Angelini Pharma S.P.A. | Activating compounds of potassium channels kv7.2/kv7.3 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4200259A1 (de) | 1992-01-08 | 1993-07-15 | Asta Medica Ag | Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung |
| HRP20240012T1 (hr) | 2019-02-06 | 2024-03-29 | Eli Lilly And Company | Derivati 1-((2-(2,2,2-trifluoroetoksi)piridin-4-il)metil)uree kao kcnq potencijatori |
| CN115461327A (zh) * | 2020-04-29 | 2022-12-09 | 爱杜西亚药品有限公司 | 螺脲衍生物 |
| AU2021295422A1 (en) * | 2020-06-25 | 2023-02-23 | Idorsia Pharmaceuticals Ltd | Cyclobutyl-urea derivatives |
-
2023
- 2023-02-09 JP JP2024547842A patent/JP2025506201A/ja active Pending
- 2023-02-09 WO PCT/US2023/012660 patent/WO2023158584A1/en not_active Ceased
- 2023-02-09 EP EP23714122.1A patent/EP4479377A1/en active Pending
- 2023-02-09 CN CN202380020956.5A patent/CN118829626A/zh active Pending
-
2024
- 2024-08-14 US US18/804,965 patent/US20250002452A1/en active Pending